Universitätsklinikum Hamburg-Eppendorf (UKE)

Development of central nervous system metastases as a first site of metastatic disease in breast cancer patients treated in the neoadjuvant trials GeparQuinto and GeparSixto (2019) Laakmann E, Witzel I, Fasching P, Rezai M, Schem C, Solbach C, Tesch H, et al. Journal article Influence of PIK3CA mutations on breast cancer proliferation, lymphocyte infiltration and clinical outcome: Pooled analysis of 484 patients from three prospective multicentre GBG trials (2019) Jank P, Loibl S, Fasching P, Karn T, Marme F, Mueller V, Schem C, et al. Conference contribution Clotting factor activity in fresh frozen plasma after thawing with a new radio wave thawing device (2019) Kuta P, Melling N, Zimmermann R, Achenbach S, Eckstein R, Strobel J Journal article Topical therapy of psoriasis vulgaris - a treatment pathway (2019) Koerber A, Wilsmann-Theis D, Augustin M, Von Kiedrowski R, Mrowietz U, Rosenbach T, Meller S, et al. Journal article Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCA (2019) Hou Y, Pinheiro J, Sahm F, Reuss DE, Schrimpf D, Stichel D, Casalini B, et al. Journal article Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 study (2019) Polterauer S, Schwameis R, Grimm C, Hillemanns P, Jückstock J, Hilpert F, de Gregorio N, et al. Journal article Ambiguous specifications about a therapy recommendation Missverständliche Angaben zu einer Therapieempfehlung (2019) Leidel BA, Dormann H, Busch HJ, Kluge S Journal article Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) (2019) Saraceni F, Labopin M, Brecht A, Kroeger N, Eder M, Tischer J, Labussiere-Wallet H, et al. Journal article A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab-pretreated patients with HER-2-positive metastatic breast cancer (E-VITA) (2019) Bischoff J, Barinoff J, Mundhenke C, Bauerschlag DO, Costa SD, Herr D, Luebbe K, et al. Journal article HSD17B13 rs72613567 TA is associated with a reduced risk for developing hepatocellular carcinoma in patients with alcohol-related cirrhosis (2019) Stickel F, Lutz P, Buch S, Fischer J, Rausch V, Silva I, Rosendahl J, et al. Conference contribution